Purchase Order 75N91021P00447

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,097.50 on May 21, 2021, for biologicals and reagents with an ultimate completion date of June 4, 2021. No set-aside was used. Performance occurs in Marshallton, Delaware. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,570.50 on July 6, 2020, for drugs and biologicals, with completion on August 6, 2020. Work is performed at Marshtonlon, Delaware. The order carries firm fixed price terms with no set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,884.50 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for BIOLOGICAL KITS. The place of performance will be in Marshallton, Delaware and the period of performance is one month from June 29, 2023 through July 31, 2023. As the prime contractor, Agilent Technologies Inc. will deliver the requested biological kits to support the...

<p>The National Cancer Institute issued a $40,929.49 delivery order to Agilent Technologies Inc. on May 18, 2020, for scientific equipment.</p> <p>Place of performance is Marshtonlon, DE. The order has a firm fixed price and an ultimate completion date of June 30, 2020. No set-aside was used.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,303.20 purchase order to Agilent Technologies Inc. Customer Service And Sales Division for the delivery of biological kits. As the prime contractor, Agilent Technologies Inc. will provide the requested biological kits to support the National Cancer Institute's research efforts. The contract has a period of performance from August 1, 2023 through September 1, 2023 and utilizes a...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,053.50 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for biological kits. The place of performance is Marshallton, Delaware and the period of performance runs through March 5, 2024. No set aside designation was used for this procurement. Agilent Technologies Inc. is a subsidiary of Agilent Technologies, which serves as a prime...

The National Cancer Institute issued a delivery order to Agilent Technologies Inc. on April 28, 2020, with a ceiling value of $11,715.60 for maintenance agreement services, with ultimate completion on April 30, 2021. Place of performance is Marshallton, DE. The order was issued under the GSA Scientific Equipment and Services Multiple Award Schedule (FSS-66), a governmentwide schedule vehicle for laboratory instrumentation, analytical equipment, and related services. Pricing was firm fixed...